Table 1. Demographic and clinical parameters of RA patients and control group.
| Nº Controls | 200 |
|---|---|
| Female/ male | 163/37 |
| Mean Age (min-max) | 48.01 (19–82) |
| Nº of patients | 156 |
| Female/ male | 152/4 |
| Mean age | 52.15 (25–77) |
| Disease Activity Score 28 joints (%) | |
| Clinical remission | 72 (46.15) |
| Moderate disease | 47 (30.12) |
| Severe disease | 37 (23.71) |
| CDAI (%) | |
| Clinical remission | 95 (58.97) |
| Moderate disease | 31 (19.87) |
| Severe disease | 30 (19.23) |
| HAQ | |
| <1 | 50 (32.05) |
| >1 | 106 (67.94) |
| Rheumatoid factor (%) | |
| Positive | 89 (57.05) |
| Negative | 37 (23.71) |
| Radiological erosions (%) | |
| Present | 87 (55.76) |
| Absent | 53 (33.97) |
| Erythrocyte sedimentation rate (ESR–mm/h) | 36.54 (0–125) |
| Disease modifying antirheumatic drugs (DMARD) | |
| Leflunomide | 29 |
| Hydroxychloroquine | 4 |
| Methotrexate | 78 |
| Prednisone | 45 |